• Citer

153P Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials

par Borinelli Franzoi, Maria ;Ameye, Lieveke;Eiger, Daniel;Piccart-Gebhart, Martine ;Brandão, Mariana ;Falbel Ponde, Noam ;Desmedt, Christine ;Cosimo, Serena Di;Paesmans, Marianne ;Caparica Bitton, Rafael ;Kotecki, Nuria ;Lambertini, Matteo ;De Angelis, Claudia;Awada, Ahmad ;de Azambuja, Evandro
Référence Annals of oncology, 31, page (S71)
Publication Publié, 2020-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	153P Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials
Auteur:	Borinelli Franzoi, Maria; Ameye, Lieveke; Eiger, Daniel; Piccart-Gebhart, Martine; Brandão, Mariana; Falbel Ponde, Noam; Desmedt, Christine; Cosimo, Serena Di; Paesmans, Marianne; Caparica Bitton, Rafael; Kotecki, Nuria; Lambertini, Matteo; De Angelis, Claudia; Awada, Ahmad; de Azambuja, Evandro
Informations sur la publication:	Annals of oncology, 31, page (S71)
Statut de publication:	Publié, 2020-05
Sujet CREF:	Cancérologie
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1016/j.annonc.2020.03.253
	info:pii/S0923753420363328